BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 17847063)

  • 1. Comparison of the pharmacokinetics of moxidectin and ivermectin after oral administration to beagle dogs.
    Al-Azzam SI; Fleckenstein L; Cheng KJ; Dzimianski MT; McCall JW
    Biopharm Drug Dispos; 2007 Nov; 28(8):431-8. PubMed ID: 17847063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and dose proportionality of oral moxidectin in beagle dogs.
    Vanapalli SR; Hung YP; Fleckenstein L; Dzimianski MT; McCall JW
    Biopharm Drug Dispos; 2002 Oct; 23(7):263-72. PubMed ID: 12355577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Faecal excretion profile of moxidectin and ivermectin after oral administration in horses.
    Pérez R; Cabezas I; Sutra JF; Galtier P; Alvinerie M
    Vet J; 2001 Jan; 161(1):85-92. PubMed ID: 11145833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetics of some injectable preparations containing ivermectin in dogs.
    Eraslan G; Kanbur M; Liman BC; Cam Y; Karabacak M; Altinordulu S
    Food Chem Toxicol; 2010; 48(8-9):2181-5. PubMed ID: 20488222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined subcutaneous administration of ivermectin and nitroxynil in sheep: age/body weight related changes to the kinetic disposition of both compounds.
    Moreno L; Ceballos L; Lifschitz A; Bistoletti M; Alvarez L; Lanusse C
    Res Vet Sci; 2010 Apr; 88(2):315-20. PubMed ID: 19892381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of absolute oral bioavailability of moxidectin in dogs using a semi-simultaneous method: influence of lipid co-administration.
    Lallemand E; Lespine A; Alvinerie M; Bousquet-Melou A; Toutain PL
    J Vet Pharmacol Ther; 2007 Oct; 30(5):375-80. PubMed ID: 17803727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of ivermectin in zebu Gobra (Bos indicus).
    Ndong TB; Kane Y; Ba MA; Sane I; Sutra JF; Alvinerie M
    Vet Parasitol; 2005 Mar; 128(1-2):169-73. PubMed ID: 15725548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of ivermectin after maternal or fetal intravenous administration in sheep.
    Pérez R; Palma C; Núñez MJ; Cox J
    J Vet Pharmacol Ther; 2008 Oct; 31(5):406-14. PubMed ID: 19000259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplacental exchange of moxidectin after maternal or fetal intravenous administration in sheep.
    Pérez R; Palma C; Núñez MJ; Navas M; Olmos G; Cox J
    J Vet Pharmacol Ther; 2009 Dec; 32(6):596-605. PubMed ID: 20444015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative plasma dispositions of ivermectin and doramectin following subcutaneous and oral administration in dogs.
    Gokbulut C; Karademir U; Boyacioglu M; McKellar QA
    Vet Parasitol; 2006 Feb; 135(3-4):347-54. PubMed ID: 16280198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma dispositions of ivermectin, doramectin and moxidectin following subcutaneous administration in rabbits.
    Gokbulut C; Biligili A; Kart A; Turgut C
    Lab Anim; 2010 Apr; 44(2):138-42. PubMed ID: 19959569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of parasitism on the pharmacokinetic disposition of ivermectin in lambs.
    Pérez R; Palma C; Cabezas I; Araneda M; Rubilar L; Alvinerie M
    J Vet Med A Physiol Pathol Clin Med; 2006 Feb; 53(1):43-8. PubMed ID: 16411909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The comparative plasma pharmacokinetics of intravenous cefpodoxime sodium and oral cefpodoxime proxetil in beagle dogs.
    Brown SA; Boucher JF; Hubbard VL; Prough MJ; Flook TF
    J Vet Pharmacol Ther; 2007 Aug; 30(4):320-6. PubMed ID: 17610405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of a novel formulation of ivermectin after administration to goats.
    González A; Sahagun AM; Diez MJ; Fernandez N; Sierra M; Garcia JJ
    Am J Vet Res; 2006 Feb; 67(2):323-8. PubMed ID: 16454640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics assessment of moxidectin long-acting formulation in cattle.
    Dupuy J; Sutra JF; Alvinerie M
    Vet Parasitol; 2007 Jul; 147(3-4):252-7. PubMed ID: 17543457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple oral dosing of ketoconazole increases dog exposure to ivermectin.
    Hugnet C; Lespine A; Alvinerie M
    J Pharm Pharm Sci; 2007; 10(3):311-8. PubMed ID: 17727794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-related plasma disposition of ivermectin following pour-on administration in goats.
    Gokbulut C; Bilgili A; Hanedan B; Aksit D; Aksoy AM; Turgut C
    Vet Parasitol; 2009 Jun; 162(3-4):342-5. PubMed ID: 19342177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the pharmacokinetics of moxidectin (Equest) and ivermectin (Eqvalan) in horses.
    Pérez R; Cabezas I; García M; Rubilar L; Sutra JF; Galtier P; Alvinerie M
    J Vet Pharmacol Ther; 1999 Jun; 22(3):174-80. PubMed ID: 10447828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breed-related plasma disposition of ivermectin following subcutaneous administration in Kilis and Damascus goats.
    Gokbulut C; Bilgili A; Hanedan B; Aksit D; Aksoy AM; Turgut C
    Res Vet Sci; 2009 Dec; 87(3):445-8. PubMed ID: 19410269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the interaction between ivermectin and albendazole following their combined use in lambs.
    Alvarez L; Lifschitz A; Entrocasso C; Manazza J; Mottier L; Borda B; Virkel G; Lanusse C
    J Vet Pharmacol Ther; 2008 Jun; 31(3):230-9. PubMed ID: 18471144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.